Printer Friendly

Articles from M2 Pharma (May 31, 2017)

1-37 out of 37 article(s)
Title Author Type Words
AOFAS elects Elaine L. Leighton, MPH, CAE as next executive director. 126
Apotex Inc and partnership awarded US FDA approval for first generic Strattera for the treatment of ADHD. 254
Asana BioSciences Starts Phase 2 Evaluation of ASN002 in NHL, CLL and MF. 241
Bayer awarded US FDA approval for myBETAapp and BETACONNECT Navigator in aid of patients living with relapsing-remitting multiple sclerosis. 269
Check-Cap Ltd anticipates USD2.69m from financing of ordinary shares and warrants. 200
Churchill Pharmaceuticals announces commercial team expansion. 187
CitiusTech BI-Clinical Earns NCQA Certification for Coverage of All HEDIS 2017 Measures. 314
CSA Medical includes Barrett's Esophagus with high grade dysplasia under truFreeze label. 193
CVS Pharmacy opens new Colorado store. 143
Eisai announces new joint antimalarial medicine research agreement with the Broad Institute. 218
Eisai extends collaboration with Charles River Laboratories International. 164
Gilead Touts Positive Phase 3 Data on Investigational Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for HIV-1. 213
Global Gastro Esophageal Reflux Disease Drug Market to Reach USD 5.38bn by 2023, Research and Markets Forecasts. 693
Guyer Named Chief Financial Officer at Invitae. 280
Histology and Cytology Market to Reach USD 26.9bn by 2025, Grand View Research Forecasts. 446
i2 Pharmaceuticals buys antibody and protein engineering technology portfolio from Sea Lane Biotechnologies for undisclosed fee. 176
ImmunoGen Amends License Agreements with Sanofi. 316
InventisBio announces USD19m investment agreement with OrbiMed Asia Partners and Lilly Asia Ventures. 178
LakePharma reports launch of Strategic Technology Agreement with Distributed Bio. 189
Lysogene completes enrolment of patients in 'Sanfilippo a Multi-national Observational Study'. 177
M Pharmaceutical reports successful US FDA Pre-IND Meeting results for obesity management drug, C-103. 179
Male Infertility Market Size to Reach USD 4.7bn by 2025, Grand View Research Forecasts. 445
MSD dispels fears for Ireland's future in pharma after Trump comments with EUR280m investment. 210
NICE approves Merck's immunotherapy drug Keytruda in first-line treatment of lung cancer patients. 164
NLS Pharma's ADHD drug sees success in mid-stage study. 184
North America Pharmacy Automation Market to Reach USD 2.7bn by 2022, Research and Markets Forecasts. 247
Pfizer granted EU approval for its meningococcal group B vaccine. 217
Pfizer Wins European Commission Approval for Trumenba to Help Prevent Meningococcal Group B Disease in Adolescents, Adults. 362
Phoenix Molecular Designs Touts Positive Preclinical Data for Targeted Triple Negative Breast Cancer Therapy. 548
ProSciento names new director. 127
Quidel Receives FDA Clearance, CLIA Waiver for Its Point-of-Care Sofia 2 Immunoassay Analyzer for Use with Sofia Influenza A+B Assay. 356
Riverchase Dermatology and Cosmetic Surgery reports purchase of Bowes Dermatology for undisclosed value. 195
Roche Australia's Valium recalled following evidence of tampering. 199
Specialty Enzymes Market to Reach USD 3,726.4m by 2025, Transparency Market Research Forecasts. 553
UAE and Roche sign agreement to enhance emergency drug stockpile. 199
Vita Risk Test Approved for US Medicare, Medicaid Programmes. 175
Zimmer Biomet approves USD0.24 per share dividend for Q2 2017. 158

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |